JonathanDSchwartzMD

Gastrointestinal Cancer, Hematologic Oncology

Adjunct Associate Professor, Medicine - Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai

Dr. Schwartz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1190 5th Ave
# Mount
New York, NY 10029
Phone+1 212-241-6756

Fax+1 212-423-0522

New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1996 - 1999
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1992 - 1996
Washington University in St. Louis School of MedicineClass of 1992

PubMed

8 citations
Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia.
Miren Lasaga, Paula Río, Amaia Vilas-Zornoza, Nuria Planell, Susana Navarro
Haematologica. 2023-10-01
12 citations
Improved collection of hematopoietic stem cells and progenitors from Fanconi anemia patients for gene therapy purposes
Julián Sevilla, Susana Navarro, Paula Río, Rebeca Sanchez-Dominguez, Josune Zubicaray
Molecular Therapy. Methods & Clinical Development. 2021-09-10
5 citations
Preclinical studies of efficacy thresholds and tolerability of a clinically ready lentiviral vector for pyruvate kinase deficiency treatment.
Susana Navarro, Oscar Quintana-Bustamante, Rebeca Sanchez-Dominguez, Sergio López-Manzaneda, Isabel Ojeda-Perez
Molecular Therapy. Methods & Clinical Development. 2021-09-10

Abstracts/Posters

Changing the Natural History of Fanconi Anemia Complementation Group-A with Gene Therapy: Early Results of U.S. Phase I Study of Lentiviral-Mediated Ex-Vivo FANCA Gene...
Jonathan D Schwartz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Hematopoietic Engraftment of Fanconi Anemia Patients through 3 Years after Gene Therapy
Jonathan D Schwartz, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Rocket Pharmaceuticals Announces Preliminary Data from Phase 1/2 Trial of RP-L201 for Leukocyte Adhesion Deficiency-IDecember 9th, 2019